 | • レポートコード：QYR9ST11812 • 出版社/出版日：QYResearch / 2019年9月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の鎌状赤血球貧血治療法市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。鎌状赤血球貧血治療法の種類別には、輸血、薬物療法、骨髄移植に、用途別には、病院、クリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・鎌状赤血球貧血治療法の種類別市場規模：輸血、薬物療法、骨髄移植 ・鎌状赤血球貧血治療法の用途別市場規模：病院、クリニック、その他 ・鎌状赤血球貧血治療法の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：BioMarin、Bluebird Bio、DeuteRx、Emmaus Medical、Gamida Cell、Global Blood Therapeutics、GlycoMimetics、Modus Therapeutics、Pfizer、Sancilio Pharmaceuticals、Sangamo Biosciences ・市場規模予測2019-2025：生産量 ・市場規模予測2019-2025：消費量 ・バリューチェーン・販売チャネル分析 ・市場機会・課題分析 ... |
Sickle cell anemia is an inherited form of anemia — a condition in which there aren’t enough healthy red blood cells to carry adequate oxygen throughout your body.In 2018, the global Sickle Cell Anemia Therapeutics market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sickle Cell Anemia Therapeutics.
This study researches the market size of Sickle Cell Anemia Therapeutics, presents the global Sickle Cell Anemia Therapeutics sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Sickle Cell Anemia Therapeutics in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Sickle Cell Anemia Therapeutics for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
This report includes the following manufacturers; we can also add the other companies as you want.
Bluebird Bio
DeuteRx
Emmaus Medical
Gamida Cell
Global Blood Therapeutics
GlycoMimetics
Modus Therapeutics
Pfizer
Sancilio Pharmaceuticals
Sangamo Biosciences
Market Segment by Product Type
Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant
Market Segment by Application
Hospitals
Clinics
Others
Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives are:
To analyze and research the global Sickle Cell Anemia Therapeutics status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Sickle Cell Anemia Therapeutics manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Sickle Cell Anemia Therapeutics are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type
1.3.2 Blood Transfusion
1.3.3 Pharmacotherapy
1.3.4 Bone Marrow Transplant
1.4 Market Segment by Application
1.4.1 Global Sickle Cell Anemia Therapeutics Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Anemia Therapeutics Market Size
2.1.1 Global Sickle Cell Anemia Therapeutics Revenue 2014-2025
2.1.2 Global Sickle Cell Anemia Therapeutics Sales 2014-2025
2.2 Sickle Cell Anemia Therapeutics Growth Rate by Regions
2.2.1 Global Sickle Cell Anemia Therapeutics Sales by Regions 2014-2019
2.2.2 Global Sickle Cell Anemia Therapeutics Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Sickle Cell Anemia Therapeutics Sales by Manufacturers
3.1.1 Sickle Cell Anemia Therapeutics Sales by Manufacturers 2014-2019
3.1.2 Sickle Cell Anemia Therapeutics Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Sickle Cell Anemia Therapeutics Revenue by Manufacturers (2014-2019)
3.2.2 Sickle Cell Anemia Therapeutics Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.3 Sickle Cell Anemia Therapeutics Price by Manufacturers
3.4 Key Manufacturers Sickle Cell Anemia Therapeutics Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Sickle Cell Anemia Therapeutics Market
3.6 Key Manufacturers Sickle Cell Anemia Therapeutics Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Blood Transfusion Sales and Revenue (2014-2019)
4.1.2 Pharmacotherapy Sales and Revenue (2014-2019)
4.1.3 Bone Marrow Transplant Sales and Revenue (2014-2019)
4.2 Global Sickle Cell Anemia Therapeutics Sales Market Share by Type
4.3 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type
4.4 Sickle Cell Anemia Therapeutics Price by Type
5 Market Size by Application
5.1 Overview
5.1 Global Sickle Cell Anemia Therapeutics Sales by Application
6 North America
6.1 North America Sickle Cell Anemia Therapeutics Breakdown Data by Company
6.2 North America Sickle Cell Anemia Therapeutics Breakdown Data by Type
6.3 North America Sickle Cell Anemia Therapeutics Breakdown Data by Application
6.4 North America Sickle Cell Anemia Therapeutics Breakdown Data by Countries
6.4.1 North America Sickle Cell Anemia Therapeutics Sales by Countries
6.4.2 North America Sickle Cell Anemia Therapeutics Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Sickle Cell Anemia Therapeutics Breakdown Data by Company
7.2 Europe Sickle Cell Anemia Therapeutics Breakdown Data by Type
7.3 Europe Sickle Cell Anemia Therapeutics Breakdown Data by Application
7.4 Europe Sickle Cell Anemia Therapeutics Breakdown Data by Countries
7.4.1 Europe Sickle Cell Anemia Therapeutics Sales by Countries
7.4.2 Europe Sickle Cell Anemia Therapeutics Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sickle Cell Anemia Therapeutics Breakdown Data by Company
8.2 Asia Pacific Sickle Cell Anemia Therapeutics Breakdown Data by Type
8.3 Asia Pacific Sickle Cell Anemia Therapeutics Breakdown Data by Application
8.4 Asia Pacific Sickle Cell Anemia Therapeutics Breakdown Data by Regions
8.4.1 Asia Pacific Sickle Cell Anemia Therapeutics Sales by Countries
8.4.2 Asia Pacific Sickle Cell Anemia Therapeutics Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Sickle Cell Anemia Therapeutics Breakdown Data by Company
9.2 Central & South America Sickle Cell Anemia Therapeutics Breakdown Data by Type
9.3 Central & South America Sickle Cell Anemia Therapeutics Breakdown Data by Application
9.4 Central & South America Sickle Cell Anemia Therapeutics Breakdown Data by Countries
9.4.1 Central & South America Sickle Cell Anemia Therapeutics Sales by Countries
9.4.2 Central & South America Sickle Cell Anemia Therapeutics Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Sickle Cell Anemia Therapeutics Breakdown Data by Type
10.2 Middle East and Africa Sickle Cell Anemia Therapeutics Breakdown Data by Application
10.3 Middle East and Africa Sickle Cell Anemia Therapeutics Breakdown Data by Countries
10.3.1 Middle East and Africa Sickle Cell Anemia Therapeutics Sales by Countries
10.3.2 Middle East and Africa Sickle Cell Anemia Therapeutics Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa
11 Company Profiles
11.1 BioMarin
11.1.1 BioMarin Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Sickle Cell Anemia Therapeutics
11.1.4 Sickle Cell Anemia Therapeutics Product Introduction
11.1.5 BioMarin Recent Development
11.2 Bluebird Bio
11.2.1 Bluebird Bio Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Sickle Cell Anemia Therapeutics
11.2.4 Sickle Cell Anemia Therapeutics Product Introduction
11.2.5 Bluebird Bio Recent Development
11.3 DeuteRx
11.3.1 DeuteRx Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Sickle Cell Anemia Therapeutics
11.3.4 Sickle Cell Anemia Therapeutics Product Introduction
11.3.5 DeuteRx Recent Development
11.4 Emmaus Medical
11.4.1 Emmaus Medical Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Sickle Cell Anemia Therapeutics
11.4.4 Sickle Cell Anemia Therapeutics Product Introduction
11.4.5 Emmaus Medical Recent Development
11.5 Gamida Cell
11.5.1 Gamida Cell Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Sickle Cell Anemia Therapeutics
11.5.4 Sickle Cell Anemia Therapeutics Product Introduction
11.5.5 Gamida Cell Recent Development
11.6 Global Blood Therapeutics
11.6.1 Global Blood Therapeutics Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Sickle Cell Anemia Therapeutics
11.6.4 Sickle Cell Anemia Therapeutics Product Introduction
11.6.5 Global Blood Therapeutics Recent Development
11.7 GlycoMimetics
11.7.1 GlycoMimetics Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Sickle Cell Anemia Therapeutics
11.7.4 Sickle Cell Anemia Therapeutics Product Introduction
11.7.5 GlycoMimetics Recent Development
11.8 Modus Therapeutics
11.8.1 Modus Therapeutics Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Sickle Cell Anemia Therapeutics
11.8.4 Sickle Cell Anemia Therapeutics Product Introduction
11.8.5 Modus Therapeutics Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Sickle Cell Anemia Therapeutics
11.9.4 Sickle Cell Anemia Therapeutics Product Introduction
11.9.5 Pfizer Recent Development
11.10 Sancilio Pharmaceuticals
11.10.1 Sancilio Pharmaceuticals Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Sickle Cell Anemia Therapeutics
11.10.4 Sickle Cell Anemia Therapeutics Product Introduction
11.10.5 Sancilio Pharmaceuticals Recent Development
11.11 Sangamo Biosciences
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Sickle Cell Anemia Therapeutics Sales Channels
12.2.2 Sickle Cell Anemia Therapeutics Distributors
12.3 Sickle Cell Anemia Therapeutics Customers
13 Market Forecast
13.1 Global Sickle Cell Anemia Therapeutics Sales and Revenue Forecast 2019-2025
13.2 Global Sickle Cell Anemia Therapeutics Sales Forecast by Type
13.3 Global Sickle Cell Anemia Therapeutics Sales Forecast by Application
13.4 Sickle Cell Anemia Therapeutics Forecast by Regions
13.4.1 Global Sickle Cell Anemia Therapeutics Sales Forecast by Regions 2019-2025
13.4.2 Global Sickle Cell Anemia Therapeutics Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Sickle Cell Anemia Therapeutics Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Sickle Cell Anemia Therapeutics Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Sickle Cell Anemia Therapeutics Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Sickle Cell Anemia Therapeutics Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Sickle Cell Anemia Therapeutics Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Sickle Cell Anemia Therapeutics Product Picture
Table Sickle Cell Anemia Therapeutics Key Market Segments
Table Major Manufacturers Sickle Cell Anemia Therapeutics Covered in This Report
Table Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$)
Figure Global Sickle Cell Anemia Therapeutics Sales Market Shar by Type 2014-2025
Figure Blood Transfusion Figures
Table Major Manufacturers of Blood Transfusion
Figure Pharmacotherapy Figures
Table Major Manufacturers of Pharmacotherapy
Figure Bone Marrow Transplant Figures
Table Major Manufacturers of Bone Marrow Transplant
Table Global Sickle Cell Anemia Therapeutics Market Share by Application 2019-2025 (K MT)
Figure Hospitals Use Case
Figure Clinics Use Case
Figure Others Use Case
Figure Sickle Cell Anemia Therapeutics Report Years Considered
Figure Global Sickle Cell Anemia Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Sickle Cell Anemia Therapeutics Sales 2014-2019 (K MT)
Table Global Sickle Cell Anemia Therapeutics Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Sickle Cell Anemia Therapeutics Sales by Regions 2014-2019 (K MT)
Table Global Sickle Cell Anemia Therapeutics Sales Market Share by Regions 2014-2019
Figure Global Sickle Cell Anemia Therapeutics Sales Market Share by Regions 2014-2019
Figure Global Sickle Cell Anemia Therapeutics Sales Market Share by Regions in 2018
Table Global Sickle Cell Anemia Therapeutics Revenue by Regions 2014-2019 (Million US$)
Table Global Sickle Cell Anemia Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Sickle Cell Anemia Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Sickle Cell Anemia Therapeutics Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Sickle Cell Anemia Therapeutics Sales by Manufacturers (2014-2019) (K MT)
Table Global Sickle Cell Anemia Therapeutics Sales Share by Manufacturers (2014-2019)
Figure Global Sickle Cell Anemia Therapeutics Sales Share by Manufacturers in 2018
Table Sickle Cell Anemia Therapeutics Revenue by Manufacturers (2014-2019) (Million USD)
Table Sickle Cell Anemia Therapeutics Revenue Share by Manufacturers (2014-2019)
Figure Sickle Cell Anemia Therapeutics Value Share by Manufacturers in 2018
Table Global Sickle Cell Anemia Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Sickle Cell Anemia Therapeutics Price (2014-2019) (USD/MT)
Table Key Manufacturers Sickle Cell Anemia Therapeutics Plants/Factories Distribution
Table Key Manufacturers Sickle Cell Anemia Therapeutics Area Served
Table Date of Key Manufacturers Enter into Sickle Cell Anemia Therapeutics Market
Table Key Manufacturers Sickle Cell Anemia Therapeutics Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Blood Transfusion Sales an目录输出!D Revenue (2014-2019) (K MT) & (Million US$)
Table Global Pharmacotherapy Sales an目录输出!D Revenue (2014-2019) (K MT) & (Million US$)
Table Global Bone Marrow Transplant Sales an目录输出!D Revenue (2014-2019) (K MT) & (Million US$)
Table Global Sickle Cell Anemia Therapeutics Sales by Type (2014-2019) (K MT)
Table Global Sickle Cell Anemia Therapeutics Sales Share by Type (2014-2019)
Figure Global Sickle Cell Anemia Therapeutics Sales Market Share by Type (2014-2019)
Figure Global Sickle Cell Anemia Therapeutics Sales Market Share by Type in 2018
Table Global Sickle Cell Anemia Therapeutics Revenue by Type (2014-2019) (Million US$)
Table Global Sickle Cell Anemia Therapeutics Revenue Share by Type (2014-2019)
Figure Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2014-2019)
Figure Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type in 2018
Table Sickle Cell Anemia Therapeutics Price by Type 2014-2019 (USD/MT)
Table Global Sickle Cell Anemia Therapeutics Sales by Application (2014-2019) (K MT)
Table Global Sickle Cell Anemia Therapeutics Sales Share by Application (2014-2019)
Figure Global Sales Sickle Cell Anemia Therapeutics Market Share by Application (2014-2019)
Figure Global Sales Sickle Cell Anemia Therapeutics Market Share by Application in 2018
Figure North America Sickle Cell Anemia Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure North America Sickle Cell Anemia Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Sickle Cell Anemia Therapeutics Sales by Company (2014-2019) (K MT)
Table North America Sickle Cell Anemia Therapeutics Sales Market Share by Company (2014-2019)
Figure North America Sickle Cell Anemia Therapeutics Sales Market Share by Company in 2018
Table North America Sickle Cell Anemia Therapeutics Sales by Type (2014-2019) (K MT)
Table North America Sickle Cell Anemia Therapeutics Sales Market Share by Type (2014-2019)
Figure North America Sickle Cell Anemia Therapeutics Market Share by Type in 2018
Table North America Sickle Cell Anemia Therapeutics Sales by Application (2014-2019) (K MT)
Table North America Sickle Cell Anemia Therapeutics Sales Market Share by Application (2014-2019)
Figure North America Sickle Cell Anemia Therapeutics Market Share by Application in 2018
Table North America Sickle Cell Anemia Therapeutics Sales by Countries (2014-2019) (K MT)
Table North America Sickle Cell Anemia Therapeutics Sales Market Share by Countries (2014-2019)
Figure North America Sickle Cell Anemia Therapeutics Sales Market Share by Countries in 2018
Table North America Sickle Cell Anemia Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table North America Sickle Cell Anemia Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Sickle Cell Anemia Therapeutics Revenue Market Share by Countries in 2018
Figure United States Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Canada Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Europe Sickle Cell Anemia Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure Europe Sickle Cell Anemia Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Sickle Cell Anemia Therapeutics Sales by Company (2014-2019) (K MT)
Table Europe Sickle Cell Anemia Therapeutics Sales Market Share by Company (2014-2019)
Figure Europe Sickle Cell Anemia Therapeutics Sales Market Share by Company in 2018
Table Europe Sickle Cell Anemia Therapeutics Sales by Type (2014-2019) (K MT)
Table Europe Sickle Cell Anemia Therapeutics Sales Market Share by Type (2014-2019)
Figure Europe Sickle Cell Anemia Therapeutics Sales Market Share by Type in 2018
Table Europe Sickle Cell Anemia Therapeutics Sales by Application (2014-2019) (K MT)
Table Europe Sickle Cell Anemia Therapeutics Sales Market Share by Application (2014-2019)
Figure Europe Sickle Cell Anemia Therapeutics Sales Market Share by Application in 2018
Table Europe Sickle Cell Anemia Therapeutics Sales by Countries (2014-2019) (K MT)
Table Europe Sickle Cell Anemia Therapeutics Sales Market Share by Countries (2014-2019)
Figure Europe Sickle Cell Anemia Therapeutics Sales Market Share by Countries in 2018
Table Europe Sickle Cell Anemia Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Europe Sickle Cell Anemia Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Europe Sickle Cell Anemia Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure France Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure UK Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Italy Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Russia Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Asia Pacific Sickle Cell Anemia Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Sickle Cell Anemia Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Sickle Cell Anemia Therapeutics Sales by Regions (2014-2019) (K MT)
Table Asia Pacific Sickle Cell Anemia Therapeutics Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Sickle Cell Anemia Therapeutics Sales Market Share by Regions in 2018
Table Asia Pacific Sickle Cell Anemia Therapeutics Sales by Type (2014-2019) (K MT)
Table Asia Pacific Sickle Cell Anemia Therapeutics Sales Market Share by Type (2014-2019)
Figure Asia Pacific Sickle Cell Anemia Therapeutics Market Share by Type in 2018
Table Asia Pacific Sickle Cell Anemia Therapeutics Sales by Application (2014-2019) (K MT)
Table Asia Pacific Sickle Cell Anemia Therapeutics Sales Market Share by Application (2014-2019)
Figure Asia Pacific Sickle Cell Anemia Therapeutics Market Share by Application in 2018
Table Asia Pacific Sickle Cell Anemia Therapeutics Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Sickle Cell Anemia Therapeutics Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Sickle Cell Anemia Therapeutics Sales Market Share by Regions in 2018
Table Asia Pacific Sickle Cell Anemia Therapeutics Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Sickle Cell Anemia Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Sickle Cell Anemia Therapeutics Revenue Market Share by Regions in 2018
Figure China Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure China Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Japan Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Korea Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure India Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Australia Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Sickle Cell Anemia Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Sickle Cell Anemia Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Sickle Cell Anemia Therapeutics Sales by Company (2014-2019) (K MT)
Table Central & South America Sickle Cell Anemia Therapeutics Sales Market Share by Company (2014-2019)
Figure Central & South America Sickle Cell Anemia Therapeutics Sales Market Share by Company in 2018
Table Central & South America Sickle Cell Anemia Therapeutics Sales by Type (2014-2019) (K MT)
Table Central & South America Sickle Cell Anemia Therapeutics Sales Market Share by Type (2014-2019)
Figure Central & South America Sickle Cell Anemia Therapeutics Market Share by Type in 2018
Table Central & South America Sickle Cell Anemia Therapeutics Sales by Application (2014-2019) (K MT)
Table Central & South America Sickle Cell Anemia Therapeutics Sales Market Share by Application (2014-2019)
Figure Central & South America Sickle Cell Anemia Therapeutics Market Share by Application in 2018
Table Central & South America Sickle Cell Anemia Therapeutics Sales by Countries (2014-2019) (K MT)
Table Central & South America Sickle Cell Anemia Therapeutics Sales Market Share by Countries (2014-2019)
Figure Central & South America Sickle Cell Anemia Therapeutics Sales Market Share by Countries in 2018
Table Central & South America Sickle Cell Anemia Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Sickle Cell Anemia Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Central & South America Sickle Cell Anemia Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (K MT)
Figure Middle East and Africa Sickle Cell Anemia Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Sickle Cell Anemia Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Sickle Cell Anemia Therapeutics Sales by Type (2014-2019) (K MT)
Table Middle East and Africa Sickle Cell Anemia Therapeutics Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Sickle Cell Anemia Therapeutics Sales Market Share by Type in 2018
Table Middle East and Africa Sickle Cell Anemia Therapeutics Sales by Application (2014-2019) (K MT)
Table Middle East and Africa Sickle Cell Anemia Therapeutics Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Sickle Cell Anemia Therapeutics Sales Market Share by Application in 2018
Table Middle East and Africa Sickle Cell Anemia Therapeutics Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Sickle Cell Anemia Therapeutics Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Sickle Cell Anemia Therapeutics Sales Market Share by Countries in 2018
Table Middle East and Africa Sickle Cell Anemia Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Sickle Cell Anemia Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Sickle Cell Anemia Therapeutics Revenue Market Share by Countries in 2018
Figure GCC Countries Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (K MT)
Figure Egypt Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (K MT)
Figure South Africa Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Sickle Cell Anemia Therapeutics Revenue Growth Rate (2014-2019) (K MT)
Table BioMarin Company Details
Table BioMarin Description and Business Overview
Table BioMarin Sickle Cell Anemia Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table BioMarin Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019)
Table BioMarin Sickle Cell Anemia Therapeutics Sales Market Share in Global Market
Table BioMarin Recent Development
Table Bluebird Bio Company Details
Table Bluebird Bio Description and Business Overview
Table Bluebird Bio Sickle Cell Anemia Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Bluebird Bio Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019)
Table Bluebird Bio Sickle Cell Anemia Therapeutics Sales Market Share in Global Market
Table Bluebird Bio Recent Development
Table DeuteRx Company Details
Table DeuteRx Description and Business Overview
Table DeuteRx Sickle Cell Anemia Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table DeuteRx Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019)
Table DeuteRx Sickle Cell Anemia Therapeutics Sales Market Share in Global Market
Table DeuteRx Recent Development
Table Emmaus Medical Company Details
Table Emmaus Medical Description and Business Overview
Table Emmaus Medical Sickle Cell Anemia Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Emmaus Medical Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019)
Table Emmaus Medical Sickle Cell Anemia Therapeutics Sales Market Share in Global Market
Table Emmaus Medical Recent Development
Table Gamida Cell Company Details
Table Gamida Cell Description and Business Overview
Table Gamida Cell Sickle Cell Anemia Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Gamida Cell Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019)
Table Gamida Cell Sickle Cell Anemia Therapeutics Sales Market Share in Global Market
Table Gamida Cell Recent Development
Table Global Blood Therapeutics Company Details
Table Global Blood Therapeutics Description and Business Overview
Table Global Blood Therapeutics Sickle Cell Anemia Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Global Blood Therapeutics Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019)
Table Global Blood Therapeutics Sickle Cell Anemia Therapeutics Sales Market Share in Global Market
Table Global Blood Therapeutics Recent Development
Table GlycoMimetics Company Details
Table GlycoMimetics Description and Business Overview
Table GlycoMimetics Sickle Cell Anemia Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table GlycoMimetics Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019)
Table GlycoMimetics Sickle Cell Anemia Therapeutics Sales Market Share in Global Market
Table GlycoMimetics Recent Development
Table Modus Therapeutics Company Details
Table Modus Therapeutics Description and Business Overview
Table Modus Therapeutics Sickle Cell Anemia Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Modus Therapeutics Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019)
Table Modus Therapeutics Sickle Cell Anemia Therapeutics Sales Market Share in Global Market
Table Modus Therapeutics Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Sickle Cell Anemia Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019)
Table Pfizer Sickle Cell Anemia Therapeutics Sales Market Share in Global Market
Table Pfizer Recent Development
Table Sancilio Pharmaceuticals Company Details
Table Sancilio Pharmaceuticals Description and Business Overview
Table Sancilio Pharmaceuticals Sickle Cell Anemia Therapeutics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Sancilio Pharmaceuticals Sickle Cell Anemia Therapeutics Sales Growth Rate (2014-2019)
Table Sancilio Pharmaceuticals Sickle Cell Anemia Therapeutics Sales Market Share in Global Market
Table Sancilio Pharmaceuticals Recent Development
Table Sangamo Biosciences Company Details
Figure Sickle Cell Anemia Therapeutics Value Chain
Table Sickle Cell Anemia Therapeutics Distributors List
Table Sickle Cell Anemia Therapeutics Customers List
Table Global Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT) & (Million US$)
Figure Global Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Global Sickle Cell Anemia Therapeutics Revenue Forecast 2019-2025 (Million US$)
Table Global Sickle Cell Anemia Therapeutics Sales Forecast by Type 2019-2025 (K MT)
Figure Global Sickle Cell Anemia Therapeutics Sales Forecast by Type 2019-2025 (K MT)
Figure Global Sickle Cell Anemia Therapeutics Sales Market Share Forecast by Type 2019-2025
Table Global Sickle Cell Anemia Therapeutics Sales Forecast by Application 2019-2025 (K MT)
Figure Global Sickle Cell Anemia Therapeutics Sales Forecast by Application 2019-2025 (K MT)
Figure Global Sickle Cell Anemia Therapeutics Sales Market Share Forecast by Application 2019-2025
Table Global Sickle Cell Anemia Therapeutics Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Sickle Cell Anemia Therapeutics Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Sickle Cell Anemia Therapeutics Sales Market Share Forecast by Regions 2019-2025
Table Global Sickle Cell Anemia Therapeutics Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Sickle Cell Anemia Therapeutics Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Sickle Cell Anemia Therapeutics Revenue Market Share Forecast by Regions 2019-2025
Table North America Sickle Cell Anemia Therapeutics Sales Forecast by Countries 2019-2025 (K MT)
Table North America Sickle Cell Anemia Therapeutics Sales Market Share Forecast by Countries 2019-2025
Table North America Sickle Cell Anemia Therapeutics Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Sickle Cell Anemia Therapeutics Revenue Market Share Forecast by Countries 2019-2025
Figure United States Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Canada Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Mexico Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Table Europe Sickle Cell Anemia Therapeutics Sales Forecast by Countries 2019-2025 (K MT)
Table Europe Sickle Cell Anemia Therapeutics Sales Market Share Forecast by Countries 2019-2025
Table Europe Sickle Cell Anemia Therapeutics Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Sickle Cell Anemia Therapeutics Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure France Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure UK Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Italy Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Russia Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Table Asia Pacific Sickle Cell Anemia Therapeutics Sales Forecast by Regions 2019-2025 (K MT)
Table Asia Pacific Sickle Cell Anemia Therapeutics Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Sickle Cell Anemia Therapeutics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Sickle Cell Anemia Therapeutics Revenue Market Share Forecast by Regions 2019-2025
Figure China Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Japan Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure South Korea Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure India Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Australia Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Indonesia Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Thailand Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Malaysia Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Philippines Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Vietnam Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Table Central & South America Sickle Cell Anemia Therapeutics Sales Forecast by Countries 2019-2025 (K MT)
Table Central & South America Sickle Cell Anemia Therapeutics Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Sickle Cell Anemia Therapeutics Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Sickle Cell Anemia Therapeutics Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Table Middle East and Africa Sickle Cell Anemia Therapeutics Sales Forecast by Regions 2019-2025 (K MT)
Table Middle East and Africa Sickle Cell Anemia Therapeutics Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Sickle Cell Anemia Therapeutics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Sickle Cell Anemia Therapeutics Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure GCC Countries Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure Egypt Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Figure South Africa Sickle Cell Anemia Therapeutics Sales Forecast 2019-2025 (K MT)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
鎌状赤血球貧血治療法の世界市場：市場規模・現状・予測 Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…- 鎌状赤血球貧血治療の世界市場：市場規模・現状・予測 Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…
- 鎌状赤血球病治療の世界市場：市場規模・現状・予測 Sickle Cell Disease (SCD) is a group of blood disorders typically inherited from a person's parents.The care of people with sickle cell disease may include infection prevention with vaccination and antibiotics, high fluid intake, folic acid supplementation and pain medication. In 2018, the global Si…
- 鎌状赤血球病治療の世界市場：市場規模・現状・予測 Sickle Cell Disease (SCD) is a group of blood disorders typically inherited from a person's parents.The care of people with sickle cell disease may include infection prevention with vaccination and antibiotics, high fluid intake, folic acid supplementation and pain medication. In 2018, the global Si…
- 鎌状赤血球病治療法の世界市場：インサイト・予測 Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. People with this disorderhave atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape…